Plasticity of smooth muscle ␣-actin gene expression in fibroblasts and vascular smooth muscle cells is mediated by opposing effects of transcriptional activators and repressors. Among these factors, three singlestranded DNA-binding proteins, Pur␣, Pur␤, and MSY1, have been implicated as coregulators of a cryptic 5-enhancer module. In this study, a molecular analysis of Pur␤, the least well characterized member of this group, was conducted. Southwestern and Northwestern blotting of purified Pur␤ deletion mutants using smooth muscle ␣-actin-derived probes mapped the minimal single-stranded DNA/RNA-binding domain to a conserved region spanning amino acids 37-263. Quantitative binding assays indicated that the relative affinity and specificity of Pur␤ for single-stranded DNA were influenced by purine/pyrimidine content; by non-conserved regions outside amino acids 37-263; and by cell-derived proteins, specifically MSY1. When overexpressed in A7r5 vascular smooth muscle cells, Pur␤ (but not Pur␣) inhibited transcription of a smooth muscle-specific mouse ␣-actin promoter transgene. Structural domains required for Pur␤ repressor activity included the minimal DNA-binding region and a C-terminal domain required for stabilizing high affinity protein and nucleic acid interactions. Pur␤ inhibitory activity in transfected A7r5 cells was potentiated by MSY1, but antagonized by serum response factor, reinforcing the idea that interplay among activators and repressors may account for phenotypic changes in smooth muscle ␣-actin-expressing cell types.
blasts contribute to aberrant neointimal growth of the vessel wall (1) (2) (3) (4) . In normal contractile VSMCs and injury-activated myofibroblasts, the biochemical hallmark of the differentiated phenotype is expression of vascular smooth muscle (VSM) ␣-actin, a cytoskeletal protein that plays an essential role in mediating both vascular and wound contraction (5) (6) (7) (8) . Importantly, reduction in cellular VSM ␣-actin expression has been reported to coincide with a switch to a more proliferative and migratory phenotype in myofibroblasts in vitro (9) and in VSMCs in vivo (10) . Thus, characterization of regulatory factors that inhibit VSM ␣-actin gene expression in these cell types may provide insight into the molecular biology governing phenotypic modulation and may also reveal targets of opportunity in the clinical management of unrestricted arterial remodeling.
The 5Ј-flanking region of the mouse VSM ␣-actin gene contains several highly conserved MCAT, CArG, and G/C-rich cis-regulatory elements that serve as binding sites for multiple positive and negative trans-acting factors present in cultured fibroblasts, undifferentiated myoblasts, and VSMCs (11) (12) (13) (14) (15) . Several of these factors, Pur␣, Pur␤, and MSY1, demonstrate preferential binding affinity for single-stranded DNA (ssDNA) and appear to function as transcriptional repressors (12, 13) , whereas other trans-acting proteins such as transcription enhancer factor-1 (TEF-1), serum response factor (SRF), and Sp1/ Sp3 have been implicated as collaborating serum-and/or transforming growth factor-␤1-responsive transcriptional activators (12, 15) . Mechanistically, association of Pur␣, Pur␤, and MSY1 with opposing stands of an asymmetric polypurine/polypyrimidine tract (PE, Ϫ195 to Ϫ165) that overlaps or is close to several core TEF-1 (MCAT, Ϫ182 to Ϫ176)-, Sp1/Sp3 (THR, Ϫ170 to Ϫ150; and TCE, Ϫ53 to Ϫ43)-, and SRF (CArG2, Ϫ120 to Ϫ111; and CArG1, Ϫ70 to Ϫ61)-binding sites has been proposed to block the enhancer activity of these composite ciselements by limiting access of certain activators to doublestranded DNA and/or by interfering with higher order interactions among TEF-1, SRF, and Sp1/Sp3 (12, 15) . Although this hypothetical mechanism of repression is consistent with in vitro DNA binding, protein interaction, and promoter mutagenesis studies previously reported (12, 13) , it is unknown whether all three ssDNA-binding proteins are functionally equivalent in terms of suppressing VSM ␣-actin promoter activity in cultured fibroblasts or VSMCs. This is a biochemically salient point because Pur proteins have been reported to bind ssDNA as either homo-or heterodimers (11, 16) and to possess markedly different transcriptional activities in other promoter and cell contexts, particularly those where YB-1, the human ortholog of MSY1, has been implicated as an essential coregulator (17, 18) .
These issues raise an important question. Which protein(s) among Pur␣, Pur␤, and MSY1 are the key player(s) in mediating repression of the VSM ␣-actin promoter in cell types associated with neointimal hyperplasia? Although the molecular properties of Pur␣ are relatively well characterized (19) , comparable knowledge about the Pur␤ isoform is lacking. For example, it is unknown whether individual Pur family members, which now include Pur␣, Pur␤, and Pur␥ (20) , are functionally redundant or distinct in terms of their ssDNA-binding and transcriptional regulatory properties. Although Pur␣ and Pur␤ are 71% identical at the amino acid level, striking differences exist near the N and C termini (21) . In light of a recent report implicating Pur␤ and MSY1 in cardiovascular remodeling in vivo (22) , the goal of this study was to characterize the biochemical and functional properties of Pur␤ in relation to its cis-element-binding partners in a well established VSMC model in vitro.
EXPERIMENTAL PROCEDURES
Oligonucleotide and Antibody Probes-The synthetic oligonucleotide probes used in this study were derived from selected sequences present in the 5Ј-region (Ϫ194 to Ϫ165) and the protein-coding region (amino acids [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] of the mouse VSM ␣-actin gene (12, 23) . Rabbit polyclonal antibodies directed against specific regions of mouse Pur␣ or Pur␤ have been characterized previously (11) .
Construction of Expression Plasmids encoding Mouse Pur␤ Deletion
Mutants-cDNAs encoding amino acids 87-324 (N87), 135-324 (N135), 186 -324 (N186), 236 -324 (N236), 263-324 (N263), and 37-263 (N37/ C263) were amplified from pCI-10-1Pur␤ (21) using Pfu polymerase (Stratagene) and primers that generate 5Ј-BamHI and 3Ј-KpnI cloning sites. The PCR products were agarose gel-purified, digested with restriction enzymes, and subcloned into pQE30 (QIAGEN Inc.) to create fusion constructs encoding His-tagged Pur␤ mutants with an N-terminal MRGSH 6 polyhistidine epitope. Plasmids were transformed into Escherichia coli strain JM109, purified, and sequenced. Mutant proteins were expressed and purified using Ni 2ϩ -NTA spin columns (QIA-GEN Inc.) as previously described (11) . C-terminal deletion mutants encoding Pur␤ amino acids 2-263 (C263), 2-236 (C236), 2-186 (C186), 2-135 (C135), and 2-87 (C87) were similarly expressed and purified using bacterial expression vectors created in an analogous manner (23) . Cytomegalovirus enhancer/promoter-driven expression plasmids encoding His-tagged Pur␤ mutants were constructed by subcloning EcoRI/ SalI cDNA fragments released from pQE30 constructs into pCI (Promega). Construction of mammalian cell expression plasmids encoding full-length His or Myc epitope-tagged Pur␣, Pur␤, MSY1, TEF-1, and SRF was described previously (12) . All plasmids used for transfection studies were purified by double cesium chloride gradient centrifugation.
Enzyme-linked Immunosorbent Assay (ELISA) for Protein-ssDNA Binding-Selected ssDNA probes were immobilized on streptavidincoated microtiter wells (StreptaWell, Roche Applied Science) by application of 10 nM 3Ј-biotinylated oligonucleotide diluted in coating buffer (20 mM HEPES (pH 7.5), 150 mM NaCl, and 1.5 mM MgCl 2 ) at 100 l/well. After a 2-h incubation at room temperature, coating buffer was removed by aspiration, and wells were rinsed twice with wash buffer (coating buffer containing 0.05% (v/v) Tween 20) . Blocking buffer (wash buffer containing 2.0% (w/v) bovine serum albumin (Sigma)) was then applied at 300 l/well. Blocking buffer was removed after 1 h, and wells were washed once. This was followed immediately by application (100 l/well) of varying amounts of either AKR-2B nuclear protein (800 -12.5 g/ml) or purified recombinant Pur␤ (100 -1.56 nM) to selected wells in duplicate. To protect against proteolysis, nuclear protein was serially diluted in ice-cold assay buffer (wash buffer containing 0.1% (w/v) bovine serum albumin and 10 g/ml poly(dI-dC)) just prior to application to the DNA-coated wells. In experiments conducted with AKR-2B nuclear protein, wells were incubated for 16 h at 4°C. In separate experiments conducted with purified recombinant Pur␤, wells were incubated for 30 min at 37°C. Protein solution containing free (i.e. unbound) Pur␤ was removed, and wells were washed three times. Rabbit anti-mouse Pur␤ antibody (antibody B302-324) diluted in assay buffer minus poly(dI-dC) to 1.0 g/ml was applied at 100 l/well. Following incubation at 37°C for 30 min, primary antibody solution was removed, and wells were washed three times. Horseradish peroxidaseconjugated goat anti-rabbit IgG secondary antibody (Santa Cruz Biotechnology, Inc.) diluted 1:8000 in wash buffer was then applied at 100 l/well. After a 30-min incubation at 37°C, wells were washed four times, and 100 l of the chromogenic horseradish peroxidase substrate ABTS ® (Roche Applied Science) was applied. Absorbance measurements at 405 nm were made ϳ10 min after addition of substrate using a microplate reader. In experiments conducted with AKR-2B nuclear protein, Pur␣ was similarly detected using a rabbit polyclonal antibody directed against the C terminus of Pur␣ (11) . In some experiments, 1 mM EDTA was used in place of 1.5 mM MgCl 2 in the coating, blocking, assay, and wash buffers to assess the requirement for divalent cations in protein-DNA interaction.
Cell Culture, Transfection, and Reporter Gene Assays-Rat A7r5 VSMCs were grown in Dulbecco's modified Eagle's medium containing 10% heat-inactivated fetal bovine serum (Hyclone Laboratories) and 1.5g/liter NaHCO 3 in a humidified incubator at 37°C and 5% CO 2 . For transient transfection experiments, 1.2 ϫ 10 5 cells were seeded on 60-mm plates and allowed to adhere overnight. Typically, cells were ϳ40 -50% confluent at the time of transfection. Cells were cotransfected with 3 g of SMP8-CAT reporter plasmid (24) , and 3 g of total expression plasmid using GenePORTER TM reagent (Gene Therapy Systems) at a ratio of 3 l/g of DNA. Control transfections were performed with pSV␤ reporter plasmid. Three hours after adding DNA, the cells were fed 1 ml of Dulbecco's modified Eagle's medium and 20% fetal bovine serum and then 2 ml of Dulbecco's modified Eagle's medium and 10% fetal bovine serum 24 h later. Forty-eight hours post-transfection, cells were washed three times with cold phosphate-buffered saline and then lysed using 0.5 ml of 1ϫ CAT lysis buffer (Roche Applied Science) containing protease inhibitors (1 mM phenylmethylsulfonyl fluoride and 1.0 g/ml each leupeptin, pepstatin, and aprotinin) for 30 min. Whole cell extracts were centrifuged at 14,000 ϫ g for 10 min at 4°C. Cleared extracts were stored at Ϫ80°C. Total protein in extracts from the transfected cells was determined using the BCA dye binding assay (Sigma). Bovine serum albumin was used as a standard. Expression of CAT and ␤-galactosidase reporters was quantified using commercial ELISAs (Roche Applied Science). Reporter values were normalized with respect to total cell protein. Transfections were routinely performed in triplicate or quadruplicate and repeated three to four times. Selected data sets were subjected to analysis of variance to assess statistical significance at p Ͻ 0.05. Post hoc comparisons were performed using Bonferroni's t test.
Immunoblotting for Detection of Transgene Expression-Equivalent amounts of lysed cell protein was precipitated by adding a 5ϫ volume of absolute ethanol to pooled extracts of transfected cells. Samples were incubated at Ϫ20°C for 1 h and then centrifuged at 14,000 ϫ g for 10 min at 4°C. Air-dried pellets were dissolved in 25 l of 2ϫ SDS-PAGE sample preparation buffer with 5% (v/v) 2-mercaptoethanol and then heated at 95°C for 3 min. Denatured proteins were separated by electrophoresis on 10% (29:1 acrylamide/bisacrylamide) minigels and then transferred to Immobilon-P TM membrane (Millipore Corp.) at 4°C in buffer consisting of 25 mM Tris (pH 8.3), 192 mM glycine, and 20% methanol for 90 min at 125 V and 250 mA. Blots were blocked overnight with 5% Carnation nonfat dry milk powder dissolved in 20 mM Tris (pH 7.5) and 150 mM NaCl at 4°C. Blots were then transferred to fresh blocking buffer containing primary antibody and incubated for 2 h. Antibody RGS⅐His TM (QIAGEN Inc.) at 250 ng/ml was used to detect His-tagged proteins (Pur␣, Pur␤, and Pur␤ mutants), whereas mouse anti-c-Myc antibody 9E10 (Santa Cruz Biotechnology, Inc.) at 100 ng/ml was employed for detection of Myc-tagged proteins (TEF-1, MSY1, and SRF). Following primary antibody incubation, blots were washed four times with 20 mM Tris (pH 7.5), 150 mM NaCl, and 0.1% (v/v) Tween 20 for a total of 30 min and then incubated with horseradish peroxidaseconjugated goat anti-mouse IgG secondary antibody (Santa Cruz Biotechnology, Inc.) at 1:2000 dilution for 1 h. Blots were washed again as described above, and bands were visualized by chemiluminescent detection (ECL TM reagent, Amersham Biosciences) as directed by the manufacturer. In some cases, blots were reprobed with mouse anti-glyceraldehyde-3-phosphate dehydrogenase antibody (Research Diagnostics Inc.) to verify equivalent protein loading. BenchMark TM prestained protein markers (Invitrogen) were used to calibrate immunoblots.
Other Analytical Methods-Northwestern blotting, Southwestern blotting, and colorimetric solid-phase binding assay for the detection of protein-nucleic acid interaction were performed as previously described (23) .
RESULTS
Mapping of the Pur␤ ssDNA/RNA-binding Domain-Bacterial expression plasmids encoding His-tagged N-and C-terminal deletion mutants of Pur␤ were constructed (Fig. 1A) . Mutant proteins were expressed in E. coli and purified using Ni 2ϩ -NTA-agarose. As shown in Fig. 1B , deletion mutants prepared in this fashion were sufficiently pure to warrant further biochemical analysis. To identify the minimal nucleic acidbinding domain of mouse Pur␤, parallel Northwestern (protein-RNA) and Southwestern (protein-DNA) blotting of N-and Cterminal deletion mutants was conducted. The ssDNA and RNA probes used in these experiments were derived from the coding region of the VSM ␣-actin gene as previously described (23) . As shown in Fig. 2 , the pattern of reactivity among the various mutants was quite similar for both probes, indicating substantial overlap in amino acid sequences that dictate ssDNA and RNA binding. With the exception of the C186 mutant (Fig. 2, lane 4) , which interacts with RNA, but not with ssDNA, mutants lacking one or more of the highly conserved basic/aromatic or acidic/leucine-rich repeat nodules failed to bind the ssDNA and RNA probes. In short, the central region spanning amino acids 37-263 constitutes the minimal singlestranded nucleic acid-binding domain of Pur␤.
Quantitative Analysis of Pur␤ ssDNA-binding Affinity-Additional qualitative and quantitative binding studies were conducted to evaluate the specificity and affinity of Pur␤ for ssDNA sequences of varying nucleotide composition in vitro. A competitive assay using the purine-rich strand of the VSM ␣-actin polypurine/polypyrimidine (Pur/Pyr) element as a probe (biotinylated PE-F) revealed striking differences in apparent affinity for the various competitor oligonucleotides tested (Fig. 3A) . Purine-rich oligonucleotides such as PE-F, CE-F, and PUR-F were more effective competitors than pyrimidine-rich oligonucleotides such as CE-R and PUR-R. CE-F and CE-R correspond to the forward and reverse stands, respectively, of the Pur␣/␤-interacting VSM ␣-actin exon 3 protein-coding element identified by our group (23, 25) . PUR-F and PUR-R correspond to the forward and reverse strands, respectively, of the human c-myc PUR element, one of the earliest Pur␣-binding sequences identified (26) . The mutant oligonucleotide designated CE-Fmu2, which is completely defective in Pur␣/␤ binding when analyzed by either band shift or pulldown assay of cell extracts (21, 23, 25) , was the least effective competitor, generating an IC 50 of ϳ180 nM versus ϳ3 nM for PE-F and CE-F, respectively (Fig. 3A) . Consistent with the results of Southwestern blotting, full-length Pur␤ and the N37/ C263 mutant both competed for biotinylated PE-F binding to immobilized wild-type Pur␤ when evaluated in the quantitative colorimetric binding assay format (Fig. 3B) . However, the data also clearly indicate that the N37/C263 mutant was a much less effective competitor than the full-length wild-type protein, implying a previously unrecognized role for the N and/or C terminus of Pur␤ in enhancing ssDNA-binding affinity by at least an order of magnitude. These results indicate that the affinity of recombinant Pur␤ for ssDNA varies greatly FIG. 1. Construction, expression, and purification of Pur␤ deletion mutants. A, cDNAs were generated by PCR and subcloned into pQE30 to generate bacterial expression plasmids encoding Pur␤ deletion mutants with an N-terminal His 6 epitope tag. Colored squares designate sequence elements as previously described (21) . B, Histagged Pur␤ mutants were purified from E. coli using Ni 2ϩ -NTA-agarose. The relative purity of each mutant protein (750 ng/lane) was assessed by reducing SDS-PAGE on a 14% minigel and staining with Coomassie Blue R-250. Molecular mass markers (shown in kilodaltons) were run in lanes 1 and 15. FL, full-length Pur␤ (amino acids 2-324). depending upon the sequence and composition of the target oligonucleotide studied and suggest that the alleged specificity for purine-rich ssDNA is not absolute, at least for the purified E. coli derived protein.
Modulation of Pur␤-ssDNA Binding by MSY1-To test the hypothesis that additional factors present within the eukaryotic cell might account for the remarkable specificity of fibroblast-and smooth muscle cell-derived Pur proteins for purinerich ssDNA (12) , binding of nuclear extract-derived Pur proteins to each strand of the Pur/Pyr element (PE-F and PE-R, respectively) was analyzed by semiquantitative ELISA. Varying amounts of AKR-2B fibroblast nuclear protein were incubated with microtiter wells coated with equimolar amounts of biotinylated PE-F or PE-R. After washing with buffer containing 0.05% (v/v) Tween 20, solid-phase Pur protein⅐ssDNA complexes were detected using rabbit antibodies that are highly specific for either Pur␣ or Pur␤ (Fig. 4 , circles and triangles, respectively). As expected based upon previous band supershift studies and pull-down assays (11, 12, 23) , fibroblast-derived Pur␣ and Pur␤ interacted exclusively with the purine-rich PE-F strand when assayed by ELISA (Fig. 4, compare closed  and opened symbols) . The pyrimidine-rich PE-R stand did not support binding of cell-derived Pur proteins in this format.
The same ELISA system was next applied using purified recombinant protein in an attempt to quantify the ssDNAbinding affinity of E. coli expressed Pur␤. Surprisingly, significant high affinity binding by His-tagged Pur␤ to both strands of the Pur/Pyr element was detected (Fig. 5A) . Inclusion of Mg 2ϩ , which has been previously reported to enhance ssDNA binding by purified Pur␣ (16), did not alter this result (Fig. 5D) , implying that the presence of other factors is likely required to impart purine-rich ssDNA-binding specificity upon Pur␤. Assuming that the E. coli derived protein was not missing some critical post-translational modification essential for ssDNAbinding specificity, it was reasoned that the most likely candidate for such an effect was MSY1, given the precedent for the capacity of human YB-1 to alter the ssDNA-binding properties of human Pur␣ in vitro (27) . As shown in Fig. 5 (C and E) , addition of excess purified MSY1 (11) eliminated the high affinity binding of Pur␤ to the pyrimidine-rich PE-R strand without disrupting Pur␤ binding to the purine-rich PE-F strand (K d(app) ϳ 1.8 Ϯ 0.2 nM in EDTA-containing buffer and ϳ0.8 Ϯ 0.1 nM in Mg 2ϩ -containing buffer) (Fig. 5 , compare C and E). These effects required saturating amounts of MSY1 with respect to Pur␤ (Fig. 5, compare B and C, 100 versus 1000 nM MSY1), suggesting that protein-protein interaction could account for the marked change in ssDNA-binding specificity of recombinant Pur␤. Alternatively, excess MSY1 may simply serve as a competitor that precludes nonspecific binding of Pur␤ to the PE-R strand. In either case, the fact remains that the presence of purified MSY1 was necessary and sufficient to impart purine-rich ssDNA-binding specificity upon E. coli derived Pur␤ and thus to mimic the results obtained with fibroblast-derived proteins (Fig. 4) .
Mapping of Pur␤ Transcriptional Regulatory Domain(s)-Transient cotransfection studies were performed with cytomegalovirus enhancer/promoter-driven expression plasmids encoding Pur␣, Pur␤, or MSY1 and a VSM ␣-actin promoter/reporter FIG. 3 . Relative affinity of recombinant Pur␤ for known ssDNA target sequences. A, His-Pur␤-coated microtiter wells (3-pmol application) were incubated with 0.5 nM biotinylated PE-F and varying amounts of the indicated oligonucleotides. After washing, solid-phase biotinylated PE-F⅐Pur␤ complexes were detected with horseradish peroxidase-conjugated streptavidin and a chromogenic substrate (23) . PE is VSM ␣-actin MCAT-containing promoter element Ϫ194 to Ϫ165 (12). CE is the VSM ␣-actin exon 3 protein-coding element (23) . PUR is the human c-myc 5Ј-Pur␣-binding element (26) . F, forward or sense strand; R, reverse or antisense strand. B, His-Pur␤-coated microtiter wells (5-pmol application) were incubated with 0.5 nM biotinylated PE-F and varying amounts of fluid-phase wild-type Pur␤ (q) or the minimal ssDNA-binding N37/C263 mutant (E). After washing, solid-phase biotinylated PE-F⅐Pur␤ complexes were detected as described for A. Data points represent the ratio of absorbance at 405 nm measured at each concentration of fluid-phase competitor to the absorbance obtained with no competitor (defined as 1).
FIG. 4.
Binding of AKR-2B fibroblast-derived Pur␣ and Pur␤ to ssDNA. Synthetic 3Ј-biotinylated oligonucleotides corresponding to the forward (PE-F) (closed symbols) and reverse (PE-R) (open symbols) strands of the VSM ␣-actin Pur/Pyr element (12) were immobilized on streptavidin-coated microtiter wells at 1 pmol/well. Wells were washed and blocked with 2% (w/v) bovine serum albumin, and then varying amounts of AKR-2B nuclear protein were applied. After a 16-h incubation at 4°C, wells were washed and incubated with rabbit polyclonal antibodies (1 g/ml) specific for either Pur␣ (circles) or Pur␤ (triangles) (11) . Immune complexes were detected using horseradish peroxidaseconjugated goat anti-rabbit IgG and a chromogenic substrate. Absorbance values at 405 nm were corrected for nonspecific antibody binding to blocked wells. construct, SMP8, which is known to drive transgene expression in smooth muscle cell-rich tissues in the mouse (24, 28) . SMP8 contains Ϫ1074 bp of the mouse VSM ␣-actin 5Ј-flanking region, 63 bp of the 5Ј-untranslated region, and ϳ2.5 kb of intron 1 upstream of the CAT reporter gene (29, 30) . Overexpression of Pur␣, Pur␤, or MSY1 individually in A7r5 cells revealed Pur␤ to be the most effective repressor of the VSM ␣-actin reporter gene in comparison with Pur␣ and MSY1 (Fig. 6A) . In fact, neither Pur␣ nor MSY1 significantly affected SMP8 activity under experimental conditions in which Pur␤ significantly inhibited promoter activity. Western blotting of lysed transfectants confirmed that His-Pur␣, His-Pur␤, and Myc-MSY1 were all expressed at comparable levels in A7r5 cells (Fig. 6B) . Thus, the results of transient transfection assays reflect real functional differences among the expressed proteins and point to the primacy of Pur␤ in terms of transcriptional repression in this context.
To map structural domains required for repression of VSM ␣-actin gene transcription by Pur␤, selected mutants were tested for functional repressor activity by transient cotransfection analysis. Consistent with the necessity for interaction with DNA, all N-and C-terminal deletion mutants that were demonstrably defective in nucleic acid-binding capacity in vitro (e.g. N87, N186, C87, and C186) were deficient in SMP8 inhibitory activity relative to wild-type Pur␤ (Fig. 7) . However, some mutants retaining the ability to bind ssDNA (e.g. C263 and N37/C263) were also deficient in transcriptional repressor activity, indicating that DNA binding was necessary but not sufficient for inhibition of SMP8. To differentiate true transcriptional repression from coactivator-dependent squelching, titration experiments were also performed. As shown in Fig.  8A , cotransfection of A7r5 cells with SMP8 and plasmid encoding full-length Pur␤ resulted in a dose-dependent decrease in CAT reporter expression. Importantly, the Pur␤ C263 mutant was a much less effective repressor compared with the fulllength protein. Wild-type Pur␤ consistently inhibited SMP8 promoter activity by Ն10-fold in early passage cells, whereas the mutant lacking amino acids 263-324 inhibited by Յ1.5-fold at an expression vector/reporter ratio of 1:1 (Figs. 6, 7 , and 8A). Western blotting of cell lysates confirmed that both full-length wild-type Pur␤ and the C263 mutant were expressed at similar levels in A7r5 cells (Fig. 8D) , indicating that the functional data reflect authentic differences in repressor activity. Moreover, the inhibitory effect of wild-type Pur␤ was promoterspecific because the activity of a viral promoter construct (pSV␤) was not altered when A7r5 cells were cotransfected at a 1:1 Pur␤ expression plasmid/reporter ratio (Fig. 8C) . As an additional positive control, the effect of SRF on SMP8 activity was also tested. This trans-activator was chosen because its expression was found to be limiting relative to TEF-1 in A7r5 nuclear extracts when evaluated by Western blotting and band shift assay (data not shown). As shown in Fig. 8B , SRF-induced SMP8 activity by ϳ4-fold at expression vector/reporter ratios Ͻ1, with squelching observed at ratios Ն1. These data are consistent with the established role of SRF as an essential activator of the VSM ␣-actin promoter (12, (31) (32) (33) (34) . It is also important to note here that the squelching effect is indicative of the participation of limiting SRF-interacting coactivators in VSM ␣-actin promoter regulation (35) and, as such, is mechanistically distinct from the dominant-negative effect of Pur␤ (compare the dose-responses in Fig. 8, A and B) . dicated that cell-derived Pur␤ can form protein⅐protein complexes with other VSM ␣-actin 5Ј-region-binding proteins, including MSY1, TEF-1, and SRF, under certain experimental conditions (11, 12, 23) . To test whether MSY1 could affect the repressor activity of Pur␤, A7r5 cells were cotransfected with the SMP8 reporter and limiting doses of Pur␤ and MSY1 expression plasmids either individually or in combination (Fig.  9A ). Under these experimental conditions, MSY1 reproducibly enhanced the potency of Pur␤ in terms of suppressing SMP8 promoter activity. This result is consistent with the ability of MSY1 to modulate the biochemical properties of Pur␤ in vitro (Fig. 5 ) and provides further support to the assertion that functional cooperation between Pur and Y-box proteins is a necessary requirement for VSM ␣-actin promoter down-regulation (12) . In contrast, coexpression of the MCAT and CArG element-binding proteins TEF-1 and SRF, respectively, had an antagonistic effect on Pur␤ repressor activity (Fig. 9B) . Because of its high endogenous levels and comparatively weak plasmid-mediated expression (data not shown), TEF-1 by itself did not achieve statistical significance in terms of opposing Pur␤-mediated repression of SMP8 (four independent experiments). However, SRF alone or in combination with TEF-1 completely rescued the SMP8 promoter from inhibition by exogenously expressed Pur␤ in A7r5 cells (Fig. 9B) . These results are consistent with the presumed roles of TEF-1 and SRF as collaborating activators of the VSM ␣-actin promoter (12) .
Modulation of Pur␤ Repressor Activity by Other VSM ␣-Actin

DISCUSSION
Neointimal hyperplasia is a common feature of atherosclerosis, restenosis after angioplasty, and transplant vasculopathy. At the cell level, overgrowth of the arterial wall is triggered by inflammatory signals that promote progressive phenotypic changes, resulting in enhanced cell proliferation and migration (1) (2) (3) . Evidence suggests that this dedifferentiation process may occur in both medial VSMCs and adventitial fibroblasts (4) , where the biochemical hallmark of cell reprogramming is alteration in expression of VSM ␣-actin, a cytoskeletal protein important for regulation of vascular contraction and cell movement (36) . Thus, elucidation of mechanisms governing expression of the VSM ␣-actin gene in cells of myogenic and fibroblastic lineage may reveal molecular targets of clinical utility in the management of atherosclerotic plaque stability and/or restenosis after surgical intervention. To this end, the primary goal of our research is to define the gene regulatory functions of a novel group of ssDNA/RNA-binding factors (Pur␣, Pur␤, and MSY1) that have been implicated as repressors of VSM ␣-actin 8), 0.3 (lanes 2, 5, and 9), 1.0 (lanes 3, 6, and 10) , or 3.0 (lanes 4, 7, and 11) g of expression plasmid was subjected to reducing SDS-PAGE on a 10% minigel and Western blot analysis to detect His-Pur␣ (lanes 2-4) , His-Pur␤ (lanes 5-7) , or Myc-MSY1 (lanes 9 -11) . The apparent sizes of prestained protein markers are indicated in kilodaltons.
FIG. 7. Truncating either the N or C terminus of Pur␤ eliminates repressor activity.
A, A7r5 VSMCs were transiently cotransfected with the SMP8-CAT reporter and expression plasmids encoding either full-length Pur␤ (FL) or selected deletion mutants at a 1:1 ratio (3 g/3 g). Control cells were transfected with the reporter plus the empty pCI expression vector. After 48 h in growth medium, cell lysates were harvested and analyzed for total cell protein and CAT enzyme. For each mutant, bars show the mean Ϯ S.D. of normalized SMP8 activity expressed relative to cells transfected with full-length Pur␤ (defined as 1). B, lysed cell protein (50 g/lane) from transfected cells was subjected to reducing SDS-PAGE on a 13% minigel and Western blot analysis to detect expression of His-Pur␤ mutants. The apparent sizes of prestained protein markers are indicated in kilodaltons. Blots were reprobed for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) to verify equivalent protein loading.
gene transcription in cultured fibroblasts and VSMCs (12) .
Pur␣ and Pur␤ are highly related proteins (71% identity at the amino acid level) that have been reported to interact with purine-rich ssDNA and RNA elements in the 5Ј-flanking and protein-coding regions of the mouse VSM ␣-actin gene (21, 23) . They are members of a newly delineated family of proteins (19, 20) whose founding member, Pur␣, appears to play a regulatory role in both cell growth (37) (38) (39) (40) and differentiation (41, 42) through interaction with specific purine-rich ssDNA or RNA target sequences and by association with key cell cycle regulatory proteins such as retinoblastoma tumor suppressor protein (38, 43) , cyclin A (38), cyclin T1 and CDK9 (44) , and E2F-1 (45) . Structurally, Pur␣ and Pur␤ are modular, each possessing alternating basic/aromatic and acidic/leucine-rich repeats ( Fig.  1 ) (21) that together constitute the minimal ssDNA/RNA-binding domain for both Pur␤ (Fig. 2) and Pur␣ (43, 46, 47) . However, in contrast to what has been previously reported for Pur␣, our quantitative analysis of Pur␤ binding to ssDNA suggests that amino acids 2-36 and 264 -324 may have an important role to play in terms of stabilizing Pur␤-ssDNA interaction because deletion of these sequences dramatically reduces the binding affinity without affecting the specificity of Pur␤ for ssDNA in vitro (Fig. 3B) . It is possible that this property is related to the putative requirement for self-association or heterodimerization among Pur proteins to manifest high affinity ssDNA binding to cis-regulatory sequences in the VSM ␣-actin gene promoter (11) and in other genes as well (16, 48) . Additional biophysical studies will be required to conclusively establish the relationship between the stoichiometry and affinity of Pur␤-nucleic acid interaction.
Although Pur␣ and Pur␤ are apparently quite similar in terms of their respective ssDNA, RNA, and protein interaction properties in vitro, it is unknown whether these proteins are was subjected to reducing SDS-PAGE on a 10% minigel and Western blot analysis to detect His-tagged full-length Pur␤ (lanes 2-4) , and His-tagged Pur␤ C263 (lanes 5-7) , or Myc-SRF (lanes 9 -11) . The apparent sizes of prestained protein markers are indicated in kilodaltons. Blots were reprobed for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) to verify equivalent protein loading.
FIG. 9.
Modulation of Pur␤ repressor activity by VSM ␣-actin enhancer-binding proteins. A, A7r5 VSMCs were transiently transfected with the SMP8-CAT reporter (3 g) and expression plasmids encoding Pur␤, MSY1, or Pur␤ plus MSY1 using the indicated amounts of plasmid in micrograms. An appropriate amount of pCI vector was added to equalize total expression plasmid at 3 g. After 48 h of growth, cell lysates were harvested and analyzed for total protein and CAT enzyme. Bars show the mean Ϯ S.E. of CAT values normalized for total cell protein expressed relative to SMP8 activity in control transfectants. B, A7r5 VSMCs were transiently transfected with the SMP8-CAT reporter (3 g) and expression plasmids encoding Pur␤ (2.0 g), TEF-1 (0.5 g), SRF (0.5 g), Pur␤ (2.0 g) plus TEF-1 (0.5 g), Pur␤ (2.0 g) plus SRF (0.5 g), or Pur␤ (2.0 g) plus TEF-1 (0.5 g) and SRF (0.5 g). An appropriate amount of pCI vector was added to equalize total expression plasmid at 3 g. After 48 h of growth, cell lysates were harvested and analyzed for total protein and CAT enzyme. Bars show the mean Ϯ S.E. of CAT values normalized for total cell protein expressed relative to SMP8 activity in control transfectants. Asterisks indicate mean SMP8 activities that statistically differ from the control with significance values of p Ͻ 0.05 (*), p Ͻ 0.01 (**), and p Ͻ 0.001 (***).
functionally redundant or distinct in terms of transcriptional activity in cultured cells. The latter situation would appear more likely because, despite their overall homology, striking sequence differences exist between Pur␣ and Pur␤, particularly near their respective C-terminal ends, where critical elements that modulate certain protein-protein interactions reside (23, 43) . To address the above issue in a VSMC context, the phenotypically homogeneous cell line A7r5 was selected for comparative overexpression experiments because of its proven utility as a model for studying regulatory networks controlling expression of markers of vascular smooth muscle differentiation (49) . Forced expression of the ssDNA-binding proteins Pur␣, Pur␤, and MSY1 in A7r5 cells suggest that, among these factors, Pur␤ is the critical component required for mediating transcriptional repression of the VSM ␣-actin gene promoter at least in this model VSMC line (Fig. 6) . The inability of the truncated Pur␤ C263 mutant to inhibit the transfected SMP8 reporter implies that amino acids 264 -324 are essential for transcriptional regulatory activity (Figs. 7 and 8) . Interestingly, this same region, which was previously implicated in mediating high affinity protein-protein interaction with Pur␣ and MSY1 (23) , is also necessary for high affinity ssDNA interaction with the purine-rich strand of the Pur/Pyr element (Fig. 3B ). This apparent trans-repression/regulatory domain is distinct from the region of the Pur␤ molecule (37-263) minimally required for lower affinity single-stranded nucleic acid binding (Figs. 2 and 3) . However, because all mutants defective in ssDNA binding in vitro (Fig. 2) also lack repressor activity when assayed in cultured cells (Fig. 7) , it follows that Pur␤ must function by a mechanism requiring high affinity ssDNA binding and protein-protein interaction. In this scenario, it is plausible to speculate that Pur␣ and MSY1 may serve obligate roles as Pur␤ cofactors. Such putative cofactor activity may be related to the reported ability of Pur␣ and YB-1/MSY1 to induce strand displacement and DNA helix destabilization in vitro (50, 51) which, if extrapolated to the context of chromatin, might expose a high affinity ssDNA-binding site for Pur␤. This suggestion is not without merit because previous in vivo footprinting studies conducted in a myofibroblast model indicated that the region surrounding the genomic VSM ␣-actin Pur/Pyr element is prone to modification by chemicals that preferentially modify unpaired bases (52) .
Further corroborative evidence for the importance of a functional interaction between Pur␤ and other nuclear factors comes from the observation that coexpression of MSY1 enhances the repressor activity of Pur␤ under experimental conditions in which Pur␤ expression is limited to levels promoting only partial (i.e. 50 -70%) inhibition (Fig. 9) . This result fits appropriately with the literature because YB-1, the human ortholog of MSY1, has also been reported to modify the ssDNAbinding affinity and trans-activator activity of human Pur␣ in a different promoter context (17) . Our additional finding indicating that MSY1 can modulate the binding specificity of Pur␤ for individual strands of the 5Ј-VSM ␣-actin Pur/Pyr element in vitro (Fig. 5) coincides with the emerging theme of physical and functional cooperation between the Pur and Y-box protein families in gene regulation (17, 18, 27) . Thus, collaborative proteinprotein and/or competitive protein-DNA interaction with cellular MSY1 may be important for mediating the ssDNA-binding affinity and specificity of Pur␤ in vivo and may explain why Pur␤ and MSY1 have been shown to be coordinately expressed in certain cell types found in mouse cardiac allografts (22) .
In the hypothetical model presented above, the functional contribution of Pur␣ remains unknown. However, given the reported ability of Pur␣ to promote helix destabilization in vitro (50) , it is conceivable that Pur␣ may serve to induce strand displacement within the Pur/Pyr element in vivo and thereby provide a high affinity ssDNA-binding site for Pur␤. Thus, it will also be important to test whether Pur␣ has any effect on the functional activity of Pur␤ in VSMCs. For example, does Pur␣ play a cofactor role similar to MSY1, or does it function as an antagonist of Pur␤? Interestingly, the ability of SRF to rescue SMP8 from inhibition by Pur␤ in A7r5 cells (Fig. 9B ) evidently places SRF into the latter category. This is not unexpected given the presumed role of SRF as a key CArG-and TEF-1-interacting trans-activator of the cryptic enhancer module and a potential target of Pur/MSY1 binding as well (12) . Although it is likely that Pur␤ and SRF exert their opposing effects on VSM ␣-actin gene transcription through interaction with distinct cis-elements, we cannot exclude the possibility that protein-protein interaction between these factors may alter their respective DNA-binding properties or their ability to associate with other essential cofactors. In the case of SRF, this is a particularly relevant issue because this ubiquitously expressed factor is generally thought to facilitate expression of genes encoding markers of myogenic differentiation by cell-and tissue-specific interaction with coactivating partners, which, in some cases, demonstrate a restricted pattern of expression in tissues enriched in smooth muscle (35, (53) (54) (55) (56) (57) (58) (59) . Moreover, because combinatorial interactions among multiple cis-elements, trans-acting factors, and cofactor proteins appear to be a key feature of VSM ␣-actin gene regulation in both VSMCs (60) and myofibroblasts (15) , it will be important to determine whether SRF can be added to the growing list of VSM ␣-actin 5Ј-binding proteins such as TEF-1 (12) and Sp1/Sp3 (12, 15, 61) that are targets of Pur␤ binding and, perhaps, transcriptional inhibition as well. Despite this complexity, these results reinforce our working hypothesis that competition among activators and repressors likely plays a pivotal role in altering VSM ␣-actin gene expression during phenotypic modulation of VSMCs and myofibroblasts.
In summary, Pur␤ is a gene regulatory protein composed of distinct ssDNA-binding and trans-repression domains. Although the minimal ssDNA/RNA-binding domain maps to a region that is highly conserved among Pur family members (21) , the transcriptional regulatory domain maps to a unique C-terminal region implicated in mediating high affinity interaction with protein-binding partners Pur␣ and MSY1 (23) and now with ssDNA (Fig. 3B) . The ssDNA-binding and transcriptional activities of Pur␤ are subject to modulation by certain other gene regulatory factors, most notably MSY1 and SRF, in either a cooperative or antagonistic manner. These results suggest that physical and functional interplay between Pur␤ and other VSM ␣-actin-associated trans-acting factors may account for the remarkable phenotypic plasticity of VSMCs.
